LEASE AGREEMENTLease Agreement • August 14th, 2000 • Praecis Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
WITNESSETH:License Agreement • February 8th, 2000 • Praecis Pharmaceuticals Inc • Pharmaceutical preparations • Indiana
WARRANT AGREEMENTPraecis Pharmaceuticals Inc • November 13th, 2000 • Pharmaceutical preparations • Illinois
JOINT FILING AGREEMENTJoint Filing Agreement • November 1st, 2001 • Praecis Pharmaceuticals Inc • Pharmaceutical preparations
The undersigned hereby agree that the Statement on this Schedule 13G/A, dated November 1, 2001, (the "Schedule 13G/A"), with respect to the Common Stock, par value $0.01 per share, of Praecis Pharmaceuticals Inc. is filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities and Exchange Act of 1934, as amended, and that this Agreement shall be included as an Exhibit to this Schedule 13G/A . Each of the undersigned agrees to be responsible for the timely filing of the Schedule 13G/A, and for the completeness and accuracy of the information concerning itself contained therein. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.
HILL BUILDING Lease to Pharmaceutical Peptides, Inc.Praecis Pharmaceuticals Inc • August 12th, 1998
EXHIBIT 10.2 EXECUTION COPY TERMINATION AGREEMENT This Termination Agreement, dated as of this 19th day of August, 2002 (the "SIGNING DATE"), is by and between PRAECIS PHARMACEUTICALS INCORPORATED, a Delaware corporation having its principal place of...Termination Agreement • November 14th, 2002 • Praecis Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
8,000,000 Shares(1) Common Stock ($.01 par value)Praecis Pharmaceuticals Inc • March 28th, 2000 • Pharmaceutical preparations • New York
Exhibit 10.4 AMENDED AND RESTATED STOCKHOLDERS AGREEMENT AMENDED AND RESTATED STOCKHOLDERS AGREEMENT dated as of April 30, 1998 (the "Agreement") by and among PRAECIS PHARMACEUTICALS INCORPORATED, a Delaware corporation (the "Company"), Malcolm L....Stockholders Agreement • March 10th, 2000 • Praecis Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
AGREEMENT BETWEENSupply Agreement • August 12th, 1998 • Praecis Pharmaceuticals Inc
AMENDMENT NO. 1 TO LICENSE AGREEMENTLicense Agreement • January 26th, 2001 • Praecis Pharmaceuticals Inc • Pharmaceutical preparations
EXHIBIT 10.13 CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR CERTAIN PORTIONS OF THIS DOCUMENT. SUCH PORTIONS HAVE BEEN REDACTED AND MARKED WITH ASTERISKS (**). THE NON-REDACTED VERSION OF THIS DOCUMENT HAS BEEN SENT TO THE SECURITIES AND EXCHANGE...Confidential Treatment • January 26th, 2001 • Praecis Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
Exhibit 10.16 EMPLOYMENT AGREEMENT BETWEEN PHARMACEUTICAL PEPTIDES, INC. ("THE COMPANY") AND MARC B. GARNICK ("THE EMPLOYEE") Commencement April 1, 1994 (commencing transition), September 1, 1994 Date (full-time). At the Company's discretion and in...Employment Agreement • August 12th, 1998 • Praecis Pharmaceuticals Inc • Massachusetts
Exhibit 10.7 AMENDMENT NO. 4 TO AMENDED AND RESTATED STOCKHOLDERS AGREEMENT AMENDMENT NO. 4 dated and effective as of September 1, 2000, to Amended and Restated Stockholders Agreement dated as of April 30, 1998 by and among PRAECIS PHARMACEUTICALS...Stockholders Agreement • November 13th, 2000 • Praecis Pharmaceuticals Inc • Pharmaceutical preparations
EXHIBIT 10.7 CONFIDENTIAL INFORMATION OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. ASTERISKS (*) DENOTE SUCH OMISSIONS. LICENSE AGREEMENTLicense Agreement • August 12th, 1998 • Praecis Pharmaceuticals Inc • New York
HILL BUILDING Lease to Pharmaceutical Peptides, Inc.Praecis Pharmaceuticals Inc • February 8th, 2000 • Pharmaceutical preparations
EXHIBIT 10.10 CONFIDENTIAL INFORMATION OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT ASTERISKS (*) DENOTE SUCH OMISSIONS DEVELOPMENT AND SUPPLY AGREEMENT (PRAECIS-149) BETWEEN...Praecis Pharmaceuticals Inc • August 12th, 1998 • Georgia
BEST PROPERTY FUND, L.P., as Seller and PRAECIS PHARMACEUTICALS INCORPORATED, as Purchaser Property:Contract of Sale • March 10th, 2000 • Praecis Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
EXHIBIT 4.3 THIS WARRANT AND SECURITIES ACQUIRED UPON THE EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "1933 ACT"). THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, OR HYPOTHECATED IN THE ABSENCE...Praecis Pharmaceuticals Inc • February 8th, 2000 • Pharmaceutical preparations • Illinois
by and betweenCollaboration and License Agreement • April 3rd, 2000 • Praecis Pharmaceuticals Inc • Pharmaceutical preparations • New York
Exhibit 10.3 GUARANTY OF COSTS AND COMPLETION This unconditional guaranty ("Guaranty") is given pursuant to the terms and conditions of the agreement dated as of even date captioned "Acquisition and Construction Loan Agreement" (the "Loan Agreement")...Praecis Pharmaceuticals Inc • August 14th, 2000 • Pharmaceutical preparations
EXHIBIT 4.4 THIS WARRANT AND ANY SECURITIES ACQUIRED UPON THE EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS THEY HAVE BEEN REGISTERED UNDER...Stock and Warrant Purchase Agreement • February 8th, 2000 • Praecis Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
EXHIBIT 10.11 CONFIDENTIAL INFORMATION OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS (*) DENOTE SUCH OMISSIONS DEVELOPMENT AND SUPPLY AGREEMENTDevelopment and Supply Agreement • April 1st, 2002 • Praecis Pharmaceuticals Inc • Pharmaceutical preparations
Exhibit 10.7 WAIVER AND AMENDMENT This Waiver and Amendment, dated as of January 26, 2001 (this "Waiver and Amendment"), waives and amends certain provisions of the Stock and Warrant Purchase Agreement, dated as of May 13, 1997 (the "Stock and Warrant...Waiver And • February 12th, 2001 • Praecis Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
6,250,000 Shares(1) Common Stock ($.01 par value)Praecis Pharmaceuticals Inc • February 14th, 2001 • Pharmaceutical preparations • New York
LEASEAttornment Agreement • February 8th, 2000 • Praecis Pharmaceuticals Inc • Pharmaceutical preparations • New Jersey
6,250,000 Shares(1) Common Stock ($.01 par value)Praecis Pharmaceuticals Inc • February 12th, 2001 • Pharmaceutical preparations • New York
Exhibit 10.2 ACQUISITION AND CONSTRUCTION LOAN AGREEMENTAcquisition and Construction Loan Agreement • August 14th, 2000 • Praecis Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
Exhibit 10.5 ENVIRONMENTAL COMPLIANCE AND INDEMNITY AGREEMENT This environmental compliance and indemnity agreement ("Environmental Indemnity" or "Agreement") is given pursuant to the terms and conditions of the agreement dated as of even date...Compliance and Indemnity Agreement • August 14th, 2000 • Praecis Pharmaceuticals Inc • Pharmaceutical preparations
RECITALSCommercial Supply Agreement • March 19th, 2003 • Praecis Pharmaceuticals Inc • Pharmaceutical preparations
COLLABORATION AGREEMENT BETWEEN HUMAN GENOME SCIENCES, INC. AND PRAECIS PHARMACEUTICALS INCORPORATEDCollaboration Agreement • February 8th, 2000 • Praecis Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
September 16, 2004 Richard W. Wagner, Ph.D.Praecis Pharmaceuticals Inc • September 21st, 2004 • Pharmaceutical preparations • Delaware
BETWEENSupply Agreement • February 8th, 2000 • Praecis Pharmaceuticals Inc • Pharmaceutical preparations • New York
RIGHTS AGREEMENTRights Agreement • January 26th, 2001 • Praecis Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
STOCK PURCHASE AGREEMENT By and Between SMITHKLINE BEECHAM CORPORATION AND GLAXO GROUP LIMITED AND PRAECIS PHARMACEUTICALS INCORPORATED Dated as of April 7, 2006Stock Purchase Agreement • August 4th, 2006 • Praecis Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
STOCK PURCHASE AGREEMENT (this “Agreement”), dated as of April 7, 2006, by and between SmithKline Beecham Corporation, a corporation organized under the laws of Pennsylvania, having a principal place of business at One Franklin Plaza, 200 N. 16th Street, Philadelphia, Pennsylvania 19102 (“SBC”) and Glaxo Group Limited, a company organized under the laws of England and Wales, having its registered office at Glaxo Wellcome House, Berkeley Avenue Greenford, Middlesex, UB6 ONN, United Kingdom (“GGL”, and with SBC collectively, the “Investor” and each sometimes referred to herein as an “Investor”), and PRAECIS PHARMACEUTICALS INCORPORATION (the “Company”), a corporation organized under the laws of Delaware with its principal place of business at 830 Winter Street, Waltham, Massachusetts 02451-1420.
AMENDMENT NO. 1 TO RIGHTS AGREEMENTRights Agreement • December 21st, 2006 • Praecis Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
AMENDMENT NO. 1, dated as of December 20, 2006 (“First Amendment”), to the Rights Agreement (the “Rights Agreement”), January 24, 2001, between PRAECIS PHARMACEUTICALS INCORPORATED, a Delaware corporation (the “Company”) and American Stock Transfer and Trust Company, a New York banking corporation, as rights agent (the “Rights Agent”).
